Project
M14-675
Completed · 2019 until 2020
Sulz Michael, Brand Stephan, Krieger-Grübel Claudia, Smolders Jolijn
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2019
End Date
2020
Financing
Industry
Brief description/objective
A Multicenter, Randomized, Double-Blind,
Placebo-Controlled Induction Study to Evaluate the
Efficacy and Safety of Upadacitinib (ABT-494) in
Subjects with Moderately to Severely Active
Ulcerative Colitis